Review
Published on 22 Mar 2021
Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.654854
- 26,040 views
- 19 citations
Type at least 3 characters
2,071 articles
articles
Original Research
Published on 19 Mar 2021
Pediatric Acute Promyelocytic Leukemia: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.642744
- 6,018 views
- 4 citations
Review
Published on 18 Mar 2021
Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.614215
- 8,651 views
- 11 citations
Case Report
Published on 18 Mar 2021
Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.601709
- 5,391 views
- 7 citations
Case Report
Published on 18 Mar 2021
Case Report: EBV-Positive Extra-Nodal Marginal Zone Lymphoma Associated With XMEN Disease Caused by a Novel Hemizygous Mutation in MAGT1
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.653266
- 3,538 views
- 7 citations
Review
Published on 18 Mar 2021
Clinical Application of Liquid Biopsy in Non-Hodgkin Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.658234
- 9,247 views
- 14 citations
Editorial
Published on 17 Mar 2021
Editorial: Genomics of Lymphoproliferative Disease
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.660016
- 2,533 views
Original Research
Published on 17 Mar 2021
The Prognostic Significance of ZNF384 Fusions in Adult Ph-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: A Comprehensive Cohort Study From a Single Chinese Center
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.632532
- 6,224 views
- 22 citations
Case Report
Published on 17 Mar 2021
Case Report: Primary NK/T Cell Lymphoma Nasal Type of the Colon With Multiple Intestinal Perforations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.577939
- 4,506 views
- 4 citations
Original Research
Published on 16 Mar 2021
High Expression of Interleukin-3 Receptor Alpha Chain (CD123) Predicts Favorable Outcome in Pediatric B-Cell Acute Lymphoblastic Leukemia Lacking Prognosis-Defining Genomic Aberrations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.614420
- 8,178 views
- 12 citations
Original Research
Published on 16 Mar 2021
Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.642005
- 9,005 views
- 19 citations
Perspective
Published on 15 Mar 2021
Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.564383
- 4,405 views
- 4 citations
Original Research
Published on 15 Mar 2021
G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.631625
- 3,793 views
- 14 citations
Brief Research Report
Published on 15 Mar 2021
The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows In Vitro Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.632181
- 5,309 views
- 5 citations
Original Research
Published on 12 Mar 2021
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.637116
- 27,894 views
- 30 citations
Brief Research Report
Published on 11 Mar 2021
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.649209
- 21,683 views
- 53 citations
Review
Published on 11 Mar 2021
Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.636633
- 10,621 views
- 36 citations
Original Research
Published on 11 Mar 2021
Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.636068
- 10,408 views
- 22 citations
Original Research
Published on 11 Mar 2021
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.628807
- 12,149 views
- 29 citations
Mini Review
Published on 10 Mar 2021
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.641613
- 11,679 views
- 9 citations
Mini Review
Published on 10 Mar 2021
Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.631570
- 3,884 views
- 9 citations
Original Research
Published on 10 Mar 2021
Single-Cell Transcriptome Analysis Identifies Ligand–Receptor Pairs Associated With BCP-ALL Prognosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.639013
- 9,245 views
- 6 citations
Original Research
Published on 10 Mar 2021
CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.618908
- 4,587 views
- 6 citations
Mini Review
Published on 09 Mar 2021
Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.650473
- 15,132 views
- 33 citations